BioCryst completes follow-on

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX), Durham, N.C. Business: Cancer, Endocrine/Metabolic, Infectious Date completed: 5/28/14 Type: Follow-on Raised: $100 million Shares: 10 million Price: $10 S...